{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:07:13Z","timestamp":1793736433690,"version":"4.6.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03254-3","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:25:14Z","timestamp":1761571514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cholestasis as a complication in Kawasaki disease: an atypical clinical presentation"],"prefix":"10.1186","volume":"30","author":[{"given":"Jiaxiang","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzhou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoping","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"3254_CR1","first-page":"178","volume":"16","author":"T Kawasaki","year":"1967","unstructured":"Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967;16:178\u2013222.","journal-title":"Arerugi"},{"key":"3254_CR2","doi-asserted-by":"publisher","DOI":"10.3400\/avd.sasvp01003","author":"K Takahashi","year":"2010","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y, Hiruta N, Naoe S. Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis. 2010. https:\/\/doi.org\/10.3400\/avd.sasvp01003.","journal-title":"Ann Vasc Dis"},{"key":"3254_CR3","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2019.00073","author":"H-O Woo","year":"2019","unstructured":"Woo H-O. Predictive risk factors of coronary artery aneurysms in Kawasaki disease. Korean J Pediatr. 2019. https:\/\/doi.org\/10.3345\/kjp.2019.00073.","journal-title":"Korean J Pediatr"},{"key":"3254_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.112.965194","author":"MH Wu","year":"2012","unstructured":"Wu MH, Chen HC, Yeh SJ, Lin MT, Huang SC, Huang SK. Prevalence and the long-term coronary risks of patients with Kawasaki disease in a general population <40 years: a national database study. Circ Cardiovasc Qual Outcomes. 2012. https:\/\/doi.org\/10.1161\/circoutcomes.112.965194.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"3254_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.073","author":"JW Newburger","year":"2016","unstructured":"Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol. 2016. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.073.","journal-title":"J Am Coll Cardiol"},{"key":"3254_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedhc.2016.07.009","author":"K Williams","year":"2017","unstructured":"Williams K. Preventing long-term cardiac damage in pediatric patients with Kawasaki disease. J Pediatr Health Care. 2017. https:\/\/doi.org\/10.1016\/j.pedhc.2016.07.009.","journal-title":"J Pediatr Health Care"},{"key":"3254_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000484","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017. https:\/\/doi.org\/10.1161\/CIR.0000000000000484.","journal-title":"Circulation"},{"key":"3254_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/chd.12502","author":"JW Newburger","year":"2017","unstructured":"Newburger JW. Kawasaki disease: medical therapies. Congenit Heart Dis. 2017. https:\/\/doi.org\/10.1111\/chd.12502.","journal-title":"Congenit Heart Dis"},{"key":"3254_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13081441","author":"C Conte","year":"2023","unstructured":"Conte C, Sogni F, Rigante D, Esposito S. An update on reports of atypical presentations of Kawasaki disease and the recognition of IVIG non-responder children. Diagnostics. 2023. https:\/\/doi.org\/10.3390\/diagnostics13081441.","journal-title":"Diagnostics"},{"key":"3254_CR10","doi-asserted-by":"publisher","DOI":"10.2188\/jea.je20110126","author":"Y Nakamura","year":"2012","unstructured":"Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009\u20132010 nationwide survey. J Epidemiol. 2012. https:\/\/doi.org\/10.2188\/jea.je20110126.","journal-title":"J Epidemiol"},{"key":"3254_CR11","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2011.41.7.394","author":"SH Yun","year":"2011","unstructured":"Yun SH, Yang NR, Park SA. Associated symptoms of Kawasaki disease. Korean Circ J. 2011. https:\/\/doi.org\/10.4070\/kcj.2011.41.7.394.","journal-title":"Korean Circ J"},{"key":"3254_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.15127","author":"R Tyagi","year":"2024","unstructured":"Tyagi R, Nagaraj D, Basu S, Gupta P, Singhal M, Pilania RK. A child with Kawasaki disease and acute pancreatitis: atypical presentation. Int J Rheum Dis. 2024. https:\/\/doi.org\/10.1111\/1756-185x.15127.","journal-title":"Int J Rheum Dis"},{"key":"3254_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-019-2284-4","author":"E Arslanoglu Aydin","year":"2019","unstructured":"Arslanoglu Aydin E, Demir S, Aydin O, Bilginer Y, Ozen S. Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature. J Med Case Rep. 2019. https:\/\/doi.org\/10.1186\/s13256-019-2284-4.","journal-title":"J Med Case Rep"},{"key":"3254_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.13586","author":"EV Manlongat","year":"2017","unstructured":"Manlongat EV, Allen WC. Incomplete Kawasaki disease presenting as bilateral hip synovitis. J Paediatr Child Health. 2017. https:\/\/doi.org\/10.1111\/jpc.13586.","journal-title":"J Paediatr Child Health"},{"key":"3254_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25596","author":"T He","year":"2021","unstructured":"He T, Yang Z, Wang X, Yang J. Kawasaki disease associated pulmonary involvement in infants. Pediatr Pulmonol. 2021. https:\/\/doi.org\/10.1002\/ppul.25596.","journal-title":"Pediatr Pulmonol"},{"key":"3254_CR16","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.232","author":"F Zulian","year":"2003","unstructured":"Zulian F, Falcini F, Zancan L, Martini G, Secchieri S, Luzzatto C, et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr. 2003. https:\/\/doi.org\/10.1067\/mpd.2003.232.","journal-title":"J Pediatr"},{"key":"3254_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01495-6","author":"M Gallerani","year":"2020","unstructured":"Gallerani M, Pala M, Fabbian F, De Giorgi A. Acute cholestasis as uncommon onset of Kawasaki disease: a case report. BMC Gastroenterol. 2020. https:\/\/doi.org\/10.1186\/s12876-020-01495-6.","journal-title":"BMC Gastroenterol"},{"key":"3254_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.738215","author":"SW Huang","year":"2021","unstructured":"Huang SW, Lin SC, Chen SY, Hsieh KS. Kawasaki disease with combined Cholestatic hepatitis and Mycoplasma pneumoniae infection: a case report and literature review. Front Pediatr. 2021. https:\/\/doi.org\/10.3389\/fped.2021.738215.","journal-title":"Front Pediatr"},{"key":"3254_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/mpg.0000000000001334","author":"R Fawaz","year":"2017","unstructured":"Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2017. https:\/\/doi.org\/10.1097\/mpg.0000000000001334.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3254_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-022-04563-z","author":"N Michihata","year":"2022","unstructured":"Michihata N, Suzuki T, Yoshikawa T, Saito K, Matsui H, Fushimi K, et al. Association between intravenous immunoglobulin dose and outcomes in patients with acute Kawasaki disease. Eur J Pediatr. 2022. https:\/\/doi.org\/10.1007\/s00431-022-04563-z.","journal-title":"Eur J Pediatr"},{"key":"3254_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.Cd004000","author":"RM Oates-Whitehead","year":"2003","unstructured":"Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2003. https:\/\/doi.org\/10.1002\/14651858.Cd004000.","journal-title":"Cochrane Database Syst Rev"},{"key":"3254_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-021-00962-4","author":"A Marchesi","year":"2021","unstructured":"Marchesi A, Rigante D, Cimaz R, Ravelli A, Tarissi de Jacobis I, Rimini A, et al. Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease. Ital J Pediatr. 2021. https:\/\/doi.org\/10.1186\/s13052-021-00962-4.","journal-title":"Ital J Pediatr"},{"key":"3254_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.895408","author":"H Yu","year":"2022","unstructured":"Yu H, Ni C, Xia Y, Li J, Hang B, Han C, et al. Characteristics of Kawasaki disease before and after the COVID-19 pandemic in a large pediatric heart disease center. Front Pediatr. 2022. https:\/\/doi.org\/10.3389\/fped.2022.895408.","journal-title":"Front Pediatr"},{"key":"3254_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2013.12.008","author":"LY Chang","year":"2014","unstructured":"Chang LY, Lu CY, Shao PL, Lee PI, Lin MT, Fan TY, et al. Viral infections associated with Kawasaki disease. J Formos Med Assoc. 2014. https:\/\/doi.org\/10.1016\/j.jfma.2013.12.008.","journal-title":"J Formos Med Assoc"},{"key":"3254_CR25","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-10-0605","author":"T Yahata","year":"2011","unstructured":"Yahata T, Suzuki C, Hamaoka A, Fujii M, Hamaoka K. Dynamics of reactive oxygen metabolites and biological antioxidant potential in the acute stage of Kawasaki disease. Circ J. 2011. https:\/\/doi.org\/10.1253\/circj.cj-10-0605.","journal-title":"Circ J"},{"key":"3254_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2002.02903.x","author":"B Granel","year":"2004","unstructured":"Granel B, Serratrice J, Ene N, Igual JP, Habib G, Disdier P, et al. Painful jaundice revealing Kawasaki disease in a young man. J Gastroenterol Hepatol. 2004. https:\/\/doi.org\/10.1111\/j.1440-1746.2002.02903.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"3254_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key344","author":"N de Graeff","year":"2019","unstructured":"de Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, et al. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative. Rheumatology. 2019. https:\/\/doi.org\/10.1093\/rheumatology\/key344.","journal-title":"Rheumatology"},{"key":"3254_CR28","doi-asserted-by":"publisher","DOI":"10.5114\/amsad.2018.74522","author":"K Ramphul","year":"2018","unstructured":"Ramphul K, Mejias SG. Kawasaki disease: a comprehensive review. Arch Med Sci Atheroscler Dis. 2018. https:\/\/doi.org\/10.5114\/amsad.2018.74522.","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"3254_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.13224","author":"S Singh","year":"2018","unstructured":"Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheum Dis. 2018. https:\/\/doi.org\/10.1111\/1756-185x.13224.","journal-title":"Int J Rheum Dis"},{"key":"3254_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58121833","author":"SA Suhaini","year":"2022","unstructured":"Suhaini SA, Azidin AH, Cheah CS, Lee Wei Li W, Khoo MS, Ismail NAS, et al. Kawasaki disease with hepatobiliary manifestations. Medicina. 2022. https:\/\/doi.org\/10.3390\/medicina58121833.","journal-title":"Medicina"},{"key":"3254_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211001712","author":"T Li","year":"2021","unstructured":"Li T, Feng J, Li N, Liu T. Correct identification of incomplete Kawasaki disease. J Int Med Res. 2021. https:\/\/doi.org\/10.1177\/03000605211001712.","journal-title":"J Int Med Res"},{"key":"3254_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318253a1d8","author":"M Ib\u00e1\u00f1ez-Alcalde","year":"2012","unstructured":"Ib\u00e1\u00f1ez-Alcalde M, S\u00e1nchez-Forte M, Gim\u00e9nez-S\u00e1nchez F, Ortega-Montes \u00c1, Mart\u00ednez-Espinosa G. Cholestasis as the initial feature of Kawasaki disease. Pediatr Infect Dis J. 2012. https:\/\/doi.org\/10.1097\/INF.0b013e318253a1d8.","journal-title":"Pediatr Infect Dis J"},{"key":"3254_CR33","doi-asserted-by":"publisher","unstructured":"Expert consensus on diagnosis and treatment of infantile cholestasis. Zhonghua Er Ke Za Zhi. 2022; 60(10). https:\/\/doi.org\/10.3760\/cma.j.cn112140-20220505-00412","DOI":"10.3760\/cma.j.cn112140-20220505-00412"},{"key":"3254_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-04420-1","author":"FR Shepherd","year":"2023","unstructured":"Shepherd FR, Davies K, Miners KL, Llewellyn-Lacey S, Kollnberger S, Redman JE, et al. The superantigens SpeC and TSST-1 specifically activate TRBV12\u20133\/12\u20134(+) memory T cells. Commun Biol. 2023. https:\/\/doi.org\/10.1038\/s42003-023-04420-1.","journal-title":"Commun Biol"},{"key":"3254_CR35","doi-asserted-by":"publisher","DOI":"10.1542\/peds.61.5.699","author":"DB Magilavy","year":"1978","unstructured":"Magilavy DB, Speert DP, Silver TM, Sullivan DB. Mucocutaneous lymph node syndrome: report of two cases complicated by gallbladder hydrops and diagnosed by ultrasound. Pediatrics. 1978. https:\/\/doi.org\/10.1542\/peds.61.5.699.","journal-title":"Pediatrics"},{"key":"3254_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3182794432","author":"M Eladawy","year":"2013","unstructured":"Eladawy M, Dominguez SR, Anderson MS, Glod\u00e9 MP. Kawasaki disease and the pediatric gastroenterologist: a diagnostic challenge. J Pediatr Gastroenterol Nutr. 2013. https:\/\/doi.org\/10.1097\/MPG.0b013e3182794432.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3254_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/0009922820903421","author":"V Yellamaty","year":"2020","unstructured":"Yellamaty V, Steele RW. Kawasaki Disease presenting as hydrops of the gallbladder. Clin Pediatr. 2020. https:\/\/doi.org\/10.1177\/0009922820903421.","journal-title":"Clin Pediatr"},{"issue":"4","key":"3254_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/PAF.0000000000000511","volume":"40","author":"F Ventura","year":"2019","unstructured":"Ventura F, Barranco R, Buffelli F, et al. Unexpected infant death due to undiagnosed biliary atresia: a case of fatal neglect. Am J Forensic Med Pathol. 2019;40(4):399\u2013402. https:\/\/doi.org\/10.1097\/PAF.0000000000000511.","journal-title":"Am J Forensic Med Pathol"},{"key":"3254_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-022-04396-6","author":"T Kakiuchi","year":"2023","unstructured":"Kakiuchi T, Nakamura M, Yoshiura M, Doi H, Kumamoto T. Kawasaki disease causing common bile duct dilatation. Indian J Pediatr. 2023. https:\/\/doi.org\/10.1007\/s12098-022-04396-6.","journal-title":"Indian J Pediatr"},{"key":"3254_CR40","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211041507","author":"L Zhao","year":"2021","unstructured":"Zhao L, Hua Y, Zhou K. Prominent gallbladder enlargement: Kawasaki disease or other congenital or acquired gallbladder disease? A case report. J Int Med Res. 2021. https:\/\/doi.org\/10.1177\/03000605211041507.","journal-title":"J Int Med Res"},{"key":"3254_CR41","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1975.01360110089016","author":"JL Ternberg","year":"1975","unstructured":"Ternberg JL, Keating JP. Acute acalculous cholecystitis: complication of other illnesses in childhood. Arch Surg. 1975. https:\/\/doi.org\/10.1001\/archsurg.1975.01360110089016.","journal-title":"Arch Surg"},{"key":"3254_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e318230c380","author":"SC Huang","year":"2011","unstructured":"Huang SC, Yang YJ. Septic shock and hypofibrinogenemia predict a fatal outcome in childhood acute acalculous cholecystitis. J Pediatr Gastroenterol Nutr. 2011. https:\/\/doi.org\/10.1097\/MPG.0b013e318230c380.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3254_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1281909","author":"YN Huang","year":"2023","unstructured":"Huang YN, Lin CY, Chi H, Chiu NC, Huang DT, Chang L, et al. Jaundice-predominant manifestation of Kawasaki disease in children. Front Pediatr. 2023. https:\/\/doi.org\/10.3389\/fped.2023.1281909.","journal-title":"Front Pediatr"},{"key":"3254_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000026238","author":"J Lee","year":"2021","unstructured":"Lee J, Lee YJ, Kim Y. Acute acalculous cholecystitis as the initial manifestation of systemic lupus erythematous: a case report. Medicine. 2021. https:\/\/doi.org\/10.1097\/md.0000000000026238.","journal-title":"Medicine"},{"key":"3254_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317699288","author":"H Yang","year":"2017","unstructured":"Yang H, Bian S, Xu D, Zhang F, Zhang X. Acute acalculous cholecystitis in patients with systemic lupus erythematosus: a unique form of disease flare. Lupus. 2017. https:\/\/doi.org\/10.1177\/0961203317699288.","journal-title":"Lupus"},{"key":"3254_CR46","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/485758","author":"CJ Chen","year":"2012","unstructured":"Chen CJ, Huang FC, Tiao MM, Huang YH, Lin LY, Yu HR, et al. Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease. Sci World J. 2012. https:\/\/doi.org\/10.1100\/2012\/485758.","journal-title":"Sci World J"},{"key":"3254_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3468(87)80600-0","author":"EA Suddleson","year":"1987","unstructured":"Suddleson EA, Reid B, Woolley MM, Takahashi M. Hydrops of the gallbladder associated with Kawasaki syndrome. J Pediatr Surg. 1987. https:\/\/doi.org\/10.1016\/s0022-3468(87)80600-0.","journal-title":"J Pediatr Surg"},{"key":"3254_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000034662","author":"C Chang","year":"2023","unstructured":"Chang C, Wang Y, Shi W, Xu H, Huang X, Jiao Y. Is conservative management a safe approach for patients with acute acalculous cholecystitis presenting with an acute abdomen? Medicine. 2023. https:\/\/doi.org\/10.1097\/md.0000000000034662.","journal-title":"Medicine"},{"key":"3254_CR49","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.10.1617","author":"DY Yi","year":"2016","unstructured":"Yi DY, Chang EJ, Kim JY, Lee EH, Yang HR. Age, predisposing diseases, and ultrasonographic findings in determining clinical outcome of acute acalculous inflammatory gallbladder diseases in children. J Korean Med Sci. 2016. https:\/\/doi.org\/10.3346\/jkms.2016.31.10.1617.","journal-title":"J Korean Med Sci"},{"key":"3254_CR50","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i43.4870","author":"D Poddighe","year":"2018","unstructured":"Poddighe D, Sazonov V. Acute acalculous cholecystitis in children. World J Gastroenterol. 2018. https:\/\/doi.org\/10.3748\/wjg.v24.i43.4870.","journal-title":"World J Gastroenterol"},{"key":"3254_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01616","author":"K Kaneko","year":"2020","unstructured":"Kaneko K, Akagawa S, Akagawa Y, Kimata T, Tsuji S. Our evolving understanding of Kawasaki disease pathogenesis: role of the gut microbiota. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.01616.","journal-title":"Front Immunol"},{"key":"3254_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71371-6","author":"J Chen","year":"2020","unstructured":"Chen J, Yue Y, Wang L, Deng Z, Yuan Y, Zhao M, et al. Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-71371-6.","journal-title":"Sci Rep"},{"key":"3254_CR53","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9698","author":"J Shen","year":"2020","unstructured":"Shen J, Ding Y, Yang Z, Zhang X, Zhao M. Effects of changes on gut microbiota in children with acute Kawasaki disease. PeerJ. 2020. https:\/\/doi.org\/10.7717\/peerj.9698.","journal-title":"PeerJ"},{"key":"3254_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1402329","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang Y, Guo C, Li M, Wang Y, Zhang L. Analysis of gut microecological characteristics and differences between children with biliary atresia and non-biliary atresia in infantile cholestasis. Front Cell Infect Microbiol. 2024. https:\/\/doi.org\/10.3389\/fcimb.2024.1402329.","journal-title":"Front Cell Infect Microbiol"},{"key":"3254_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14777","author":"J Wang","year":"2020","unstructured":"Wang J, Qian T, Jiang J, Yang Y, Shen Z, Huang Y, et al. Gut microbial profile in biliary atresia: a case-control study. J Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1111\/jgh.14777.","journal-title":"J Gastroenterol Hepatol"},{"key":"3254_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698900","author":"W Song","year":"2021","unstructured":"Song W, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG, et al. Association of gut microbiota and metabolites with disease progression in children with Biliary atresia. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.698900.","journal-title":"Front Immunol"},{"key":"3254_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00830-x","author":"D Sun","year":"2024","unstructured":"Sun D, Xie C, Zhao Y, Liao J, Li S, Zhang Y, et al. The gut microbiota-bile acid axis in cholestatic liver disease. Mol Med. 2024. https:\/\/doi.org\/10.1186\/s10020-024-00830-x.","journal-title":"Mol Med"},{"key":"3254_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00824","author":"A Kinumaki","year":"2015","unstructured":"Kinumaki A, Sekizuka T, Hamada H, Kato K, Yamashita A, Kuroda M. Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis. Front Microbiol. 2015. https:\/\/doi.org\/10.3389\/fmicb.2015.00824.","journal-title":"Front Microbiol"},{"key":"3254_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27689-4","author":"JJ Jee","year":"2022","unstructured":"Jee JJ, Yang L, Shivakumar P, Xu PP, Mourya R, Thanekar U, et al. Maternal regulation of biliary disease in neonates via gut microbial metabolites. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-021-27689-4.","journal-title":"Nat Commun"},{"key":"3254_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmy063","author":"J Plaza-Diaz","year":"2019","unstructured":"Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv Nutr. 2019. https:\/\/doi.org\/10.1093\/advances\/nmy063.","journal-title":"Adv Nutr"},{"key":"3254_CR61","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112138-20211112-00795","author":"Chinese Medical Association and others","year":"2021","unstructured":"Chinese Medical Association and others. Guidelines on the management of cholestasis liver diseases (2021). Zhonghua Nei Ke Za Zhi. 2021. https:\/\/doi.org\/10.3760\/cma.j.cn112138-20211112-00795.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"3254_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-51","author":"DY Yi","year":"2014","unstructured":"Yi DY, Kim JY, Choi EY, Choi JY, Yang HR. Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children. BMC Pediatr. 2014. https:\/\/doi.org\/10.1186\/1471-2431-14-51.","journal-title":"BMC Pediatr"},{"key":"3254_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-015-0900-3","author":"L Liu","year":"2016","unstructured":"Liu L, Yin W, Wang R, Sun D, He X, Ding Y. The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysis. Inflamm Res. 2016. https:\/\/doi.org\/10.1007\/s00011-015-0900-3.","journal-title":"Inflamm Res"},{"key":"3254_CR64","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2182","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics. 2004. https:\/\/doi.org\/10.1542\/peds.2004-2182.","journal-title":"Pediatrics"},{"key":"3254_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0602","author":"A Geier","year":"2006","unstructured":"Geier A, Fickert P, Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol. 2006. https:\/\/doi.org\/10.1038\/ncpgasthep0602.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"3254_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248812","author":"X Zheng","year":"2021","unstructured":"Zheng X, Li J, Yue P, Liu L, Li J, Zhou K, et al. Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis. PLoS ONE. 2021. https:\/\/doi.org\/10.1371\/journal.pone.0248812.","journal-title":"PLoS ONE"},{"key":"3254_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2017.05.019","author":"P Hu","year":"2017","unstructured":"Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, et al. TNF-\u03b1 is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease. Clin Chim Acta. 2017. https:\/\/doi.org\/10.1016\/j.cca.2017.05.019.","journal-title":"Clin Chim Acta"},{"key":"3254_CR68","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfac030","author":"K Vlasakova","year":"2022","unstructured":"Vlasakova K, Bourque J, Bailey WJ, Patel S, Besteman EG, Gonzalez RJ, et al. Universal accessible biomarkers of drug-induced tissue injury and systemic inflammation in rat: performance assessment of TIMP-1, A2M, AGP, NGAL, and albumin. Toxicol Sci. 2022. https:\/\/doi.org\/10.1093\/toxsci\/kfac030.","journal-title":"Toxicol Sci"},{"key":"3254_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3370-2","author":"Y Tang","year":"2016","unstructured":"Tang Y, Yan W, Sun L, Huang J, Qian W, Ding Y, et al. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population. Clin Rheumatol. 2016. https:\/\/doi.org\/10.1007\/s10067-016-3370-2.","journal-title":"Clin Rheumatol"},{"key":"3254_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-017-0149-1","author":"T Xie","year":"2017","unstructured":"Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, et al. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol Online J. 2017. https:\/\/doi.org\/10.1186\/s12969-017-0149-1.","journal-title":"Pediatr Rheumatol Online J"},{"key":"3254_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-022-04131-1","author":"X Zhu","year":"2022","unstructured":"Zhu X, Fu J, Yang Y. Cholestatic jaundice as atypical initial feature of Kawasaki disease. Indian J Pediatr. 2022. https:\/\/doi.org\/10.1007\/s12098-022-04131-1.","journal-title":"Indian J Pediatr"},{"issue":"6","key":"3254_CR72","first-page":"779","volume":"18","author":"F Falcini","year":"2000","unstructured":"Falcini F, Resti M, Azzari C, Simonini G, Veltroni M, Lionetti P. Acute febrile cholestasis as an inaugural manifestation of Kawasaki\u2019s disease. Clin Exp Rheumatol. 2000;18(6):779\u201380.","journal-title":"Clin Exp Rheumatol"},{"key":"3254_CR73","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181d2bb0b","author":"R Cherry","year":"2010","unstructured":"Cherry R, Naon H, Cohen H, Takahashi M, Kaminsky C, Mason W. Common bile duct stenosis and pancreatitis in Kawasaki disease: two cases and a review of the literature. Pediatr Infect Dis J. 2010. https:\/\/doi.org\/10.1097\/INF.0b013e3181d2bb0b.","journal-title":"Pediatr Infect Dis J"},{"key":"3254_CR74","first-page":"5","volume":"30","author":"S Amano","year":"1980","unstructured":"Amano S, Hazama F, Kubagawa H, Tasaka K, Haebara H, Hamashima Y. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn. 1980;30:5.","journal-title":"Acta Pathol Jpn"},{"key":"3254_CR75","doi-asserted-by":"publisher","DOI":"10.1086\/315832","author":"AH Rowley","year":"2000","unstructured":"Rowley AH, Shulman ST, Mask CA, Finn LS, Terai M, Baker SC, et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis. 2000. https:\/\/doi.org\/10.1086\/315832.","journal-title":"J Infect Dis"},{"key":"3254_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051107","author":"H Wu","year":"2021","unstructured":"Wu H, Chen C, Ziani S, Nelson LJ, \u00c1vila MA, Nevzorova YA, et al. Fibrotic events in the progression of cholestatic liver disease. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10051107.","journal-title":"Cells"},{"issue":"2","key":"3254_CR77","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/14740338.2017.1270264","volume":"16","author":"I Kyriakidis","year":"2017","unstructured":"Kyriakidis I, Tragiannidis A, Munchen S, Groll AH. Clinical hepatotoxicity associated with antifungal agents. Expert Opin Drug Saf. 2017;16(2):149\u201365. https:\/\/doi.org\/10.1080\/14740338.2017.1270264.","journal-title":"Expert Opin Drug Saf"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03254-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03254-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03254-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:05:02Z","timestamp":1761908702000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03254-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3254"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03254-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study involved only retrospective analysis of anonymized archival data, ethical approval was not required. Written informed consent to participate in this study was provided by the participants\u2019 legal guardian\/next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1025"}}